This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
24-26 Feb, 2026
Grand Nikko Tokyo DaibaTokyo

Katsuto Tamai, M.D, PhD
Osaka University Graduate School of Medicine における CSO and Director of StemRIM Inc. and Guest Professor
スピーカー

アジェンダセッション

  • Development of novel modality peptide drug: tissue regeneration-inducing medicine

    5:00pm